Jasper Therapeutics, Inc.JSPRWNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+30.0%
5Y CAGR+72.8%
Year-over-Year Change

Research and development spending

3Y CAGR
+30.0%/yr
Annual compound
5Y CAGR
+72.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
15.4x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
2024$55.82M+7.8%
2023$51.78M+49.6%
2022$34.63M+36.2%
2021$25.42M+60.1%
2020$15.88M+339.0%
2019$3.62M-